Rational strategy for solid form research in drug development and life cycle management

• 作 者: YanfengZhang;
• 机 构: Scientific Officer (CSO) of Crystal Pharmatech
• 出 处: 2015年中国药物制剂大会、中国药学会药剂专业委员会2015年学术年会暨国际控释协会中国分会2015年学术年会
• 发表日期: 2015年期

　　The number of challenging drug candidates coming through development has increased over the years.As scientific complexity of drug development increases, the challenge to bring about the optimal development path for both drug substance (API) and drug product (formulation) is of utmost importance.